Rankings
▼
Calendar
XLO FY 2019 Earnings — Xilio Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
XLO
Xilio Therapeutics, Inc.
$29M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$240,000
Operating Income
-$19M
Net Income
-$17M
EPS (Diluted)
$-0.06
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$112,000
Balance Sheet
Total Assets
$63M
Total Liabilities
$24M
Stockholders' Equity
$39M
Cash & Equivalents
$49M
← Q1 2020
All Quarters